Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35479 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Ting Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Mar…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Intramural Research Program.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is highly fatal, with incidence rising worldwide. Metabolomics may provide insight into etiology and mechanisms contributing to pancreatic carcinogenesis. We examined associations between 1483 prediagnostic (up to 24 years) serum metabolites and PDAC in nested case–control studies within a cohort of male Finnish smokers and another of American men and women ( n = 732 matched pairs). We used conditional logistic regression to calculate odds ratios (OR) and 95% confidence intervals per standard deviation increase in log‐metabolite level within each cohort and combined using fixed‐effect meta‐analyses. We performed elastic net regression (EN) to select metabolites and calculated area under the curve (AUC) for established PDAC risk factors (smoking, diabetes, and overweight/obesity), selected metabolites, and their combination. Sixty‐six metabolites were associated with PDAC at false discovery rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
- Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
- Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Rockville, Maryland, USA.
ORCID-Profile: Ting Zhang, Rachael Z Stolzenberg-Solomon
Förderung
- Intramural NIH HHS
- Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
- Intramural Research Program
- NCI NIH HHS
- NIH HHS
- Division of Cancer Epidemiology and Genetics
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Zhang, T., Moore, S. C., Fu, S., Wang, X., Albanes, D., Weinstein, S. J., Yu, K., & Stolzenberg-Solomon, R. Z. (2025). Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. International Journal of Cancer. https://doi.org/10.1002/ijc.35479
Vancouver
Zhang T, Moore SC, Fu S, Wang X, Albanes D, Weinstein SJ, et al. Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. International Journal of Cancer. 2025. doi:10.1002/ijc.35479
BibTeX
@article{Zhang2025,
author = {Zhang, Ting and Moore, Steven C and Fu, Sheng and Wang, Xiaoyu and Albanes, Demetrius and Weinstein, Stephanie J and Yu, Kai and Stolzenberg-Solomon, Rachael Z},
title = {Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35479}
}
EUVIMED